
Interim Safety and Efficacy Results from a Phase 1 Study of NT219 in Adults with Advanced Solid Tumors
Jun 16, 2022
inPresented at the ASCO annual meeting 2022
Publication Posts
Presented at the ASCO annual meeting 2022
Presented at the AACR annual meeting April, 2022
Published in Nature Cancer, October 2021
Presented at the ESMO annual meeting 2021
Presented at ASCO annual meeting 2021
Presented at the AACR annual meeting 2021